Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Chongqing Zhifei Biological Products (300122 CH)
Watchlist
92
Analysis
Health Care
•
China
Chongqing Zhifei Biological Products Company Ltd. researches, manufactures, and sells vaccines and biological products including prevention products, blood products, diagnostic reagents, and therapeutic agents.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Beijing Wantai Biological Phar
•
27 Mar 2024 18:18
Beijing Wantai Biological (603392 CH): Struggling to Make a Mark in Murky China HPV Vaccine Market
Beijing Wantai expects 70%+ decline in net profit in 2023 due to competition. Going ahead, competition is expected to intensify further in China...
Tina Banerjee
Follow
451 Views
Share
bearish
•
Quantitative Analysis
•
26 Nov 2023 10:15
Northbound Flows (Nov 24th): Chongqing Changan Automobile, Sokon, Sungrow Power, BYD
We analyzed northbound Shanghai/Shenzhen connect flows in the past week and highlight flows for Chongqing Changan Automobile, Sokon, Sungrow Power...
Ke Yan, CFA, FRM
Follow
402 Views
Share
bullish
•
Thematic (Sector/Industry)
•
06 Jul 2023 08:55
2023H2 China Healthcare Investment Strategy and Top Pick
There're structural opportunity in China healthcare in 23H2. We advise investors not to miss out.Risks remain, offloading after rebound is...
Xinyao (Criss) Wang
Follow
532 Views
Share
bullish
•
CanSino Biologics
•
29 Mar 2023 08:55
CanSino Biologics (6185.HK) 2022 Results - It Is Time to Reassess CanSino and Its Future Prospects
CanSino had poor performance last year,but share price could bounce back in the next “sector resonance".There's no long-term investment value until...
Xinyao (Criss) Wang
Follow
274 Views
Share
bullish
•
CanSino Biologics
•
05 Feb 2023 09:27
China Healthcare Weekly (Feb.3)- CanSino, Blood Products Shortage, Don't Be Greedy in Front of Rally
Contradiction between blood products supply and demand is intensifying. Cansino plans to IPO in Swiss -We see upside potential in...
Xinyao (Criss) Wang
Follow
370 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.30.3
x